Matthew Thomas Duvernay

机构：Cartesian Therapeutics, Inc. (United States)

发表论文 61 篇 · 总被引 1726 次 · h-index 21

代表论文

• Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study (2023 · The Lancet Neurology · 被引 277)
• The role of coagulation and platelets in colon cancer-associated thrombosis (2018 · American Journal of Physiology-Cell Physiology · 被引 79)
• Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets (2013 · Molecular Pharmacology · 被引 74)
• Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions (2018 · Platelets · 被引 44)
• Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets (2016 · Molecular Pharmacology · 被引 44)
• α2B-Adrenergic Receptor Interaction with Tubulin Controls Its Transport from the Endoplasmic Reticulum to the Cell Surface (2011 · Journal of Biological Chemistry · 被引 43)